Tag: Priority
Latest article
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Superior therapy for diabetes sought
MANAMA: Experts have taken new steps that include early genetic screening and the introduction of advanced technologies to fight diabetes.
The recommendations were made yesterday...
